The Point of Care Glucose Testing Market size is expected to grow at an annual average of 10% during 2021-2027. Point-of-care examinations (POCTs) are also known as close-patient examinations used to monitor people with diabetes. Point-of-care blood glucose testing is a valuable tool used to manage diabetic patients in an outpatient setting. Additionally, point-of-care blood glucose testing devices and electronic medical records allow immediate sharing of test results with health care providers.
(Get 15% Discount on Buying this Report)
A full report of Point of Care Glucose Testing Market is available at: https://www.orionmarketreports.com/point-of-care-glucose-testing-market/37885/
The following segmentation are covered in this report:
By Platform
- Lateral Flow Assays
- Immunoassays
- Microfluidics 1
- Molecular Diagnostics
- Dipsticks
By End-use
- Outpatient & Ambulatory Care Facilities
- Hospitals & Critical Care Centers
- Home Care Settings 5
- Other End Users
Company Profile
- Roche Diabetes Care
- LifeScan IP Holdings, LLC.
- Abbott
- Ascensia Diabetes Care
- Trividia Health
- Nova Biomedical
The report covers the following objectives:
- Proliferation and maturation of trade in the global Point of Care Glucose Testing Market
- The market share of the global Point of Care Glucose Testing Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Point of Care Glucose Testing Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Point of Care Glucose Testing Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
